Your browser doesn't support javascript.
loading
Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions.
Lienhardt, Christian; Lönnroth, Knut; Menzies, Dick; Balasegaram, Manica; Chakaya, Jeremiah; Cobelens, Frank; Cohn, Jennifer; Denkinger, Claudia M; Evans, Thomas G; Källenius, Gunilla; Kaplan, Gilla; Kumar, Ajay M V; Matthiessen, Line; Mgone, Charles S; Mizrahi, Valerie; Mukadi, Ya-Diul; Nguyen, Viet Nhung; Nordström, Anders; Sizemore, Christine F; Spigelman, Melvin; Squire, S Bertel; Swaminathan, Soumya; Van Helden, Paul D; Zumla, Alimuddin; Weyer, Karin; Weil, Diana; Raviglione, Mario.
Afiliação
  • Lienhardt C; World Health Organisation, Geneva, Switzerland.
  • Lönnroth K; World Health Organisation, Geneva, Switzerland.
  • Menzies D; Montreal Chest Institute, McGill University, Montreal, Canada.
  • Balasegaram M; Access Campaign, Médecins Sans Frontières, Geneva, Switzerland.
  • Chakaya J; Centre for Respiratory Diseases Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
  • Cobelens F; Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.
  • Cohn J; Access Campaign, Médecins Sans Frontières, Geneva, Switzerland.
  • Denkinger CM; FIND Diagnostics, Geneva, Switzerland.
  • Evans TG; Aeras, Rockville, Maryland, United States of America.
  • Källenius G; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
  • Kaplan G; Bill & Melinda Gates Foundation, Seattle, Washington, United States of America.
  • Kumar AM; International Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office, New Delhi, India.
  • Matthiessen L; DG Research & Innovation, European Commission, Brussels, Belgium.
  • Mgone CS; The European & Developing Countries Clinical Trials Partnership (EDCTP), The Hague, The Netherlands.
  • Mizrahi V; Institute of Infectious Disease & Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Mukadi YD; USAID, Washington, D.C., United States of America.
  • Nguyen VN; National TB Programme, National Lung Hospital, Hanoi, Viet Nam.
  • Nordström A; Ambassador for Global Health, Ministry for Foreign Affairs, Stockholm, Sweden.
  • Sizemore CF; Tuberculosis, Leprosy and other Mycobacterial Diseases Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America.
  • Spigelman M; Global Alliance for TB Drug Development, New York, New York, United States of America.
  • Squire SB; Centre for Applied Health Research & Delivery, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Swaminathan S; National Institute for Research in Tuberculosis (NIRT), Indian Council of Medical Research, Chennai, India.
  • Van Helden PD; DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  • Zumla A; Division of Infection and Immunity, University College London Medical School, London, United Kingdom.
  • Weyer K; World Health Organisation, Geneva, Switzerland.
  • Weil D; World Health Organisation, Geneva, Switzerland.
  • Raviglione M; World Health Organisation, Geneva, Switzerland.
PLoS Med ; 13(3): e1001965, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26933883

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pesquisa / Tuberculose / Saúde Global / Vacinas contra a Tuberculose / Tuberculose Latente / Erradicação de Doenças / Acessibilidade aos Serviços de Saúde / Antituberculosos Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pesquisa / Tuberculose / Saúde Global / Vacinas contra a Tuberculose / Tuberculose Latente / Erradicação de Doenças / Acessibilidade aos Serviços de Saúde / Antituberculosos Aspecto: Determinantes_sociais_saude Limite: Humans Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Suíça